Content about Bacteria

February 28, 2014

Lupin announced that it received approval from the Food and Drug Administration for rifabutin capsules USP, 150-mg, a generic version of Pharmacia and Upjohn Company's Mycobutin capsules.

MUMBAI and BALTIMORE — Lupin on Wednesday announced that it received approval from the Food and Drug Administration for rifabutin capsules USP, 150 mg — a generic version of Pharmacia and Upjohn Company's Mycobutin capsules. The company's U.S. subsidiary will begin marketing the product soon.

The drug is used for the prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection. Mycobutin capsules had annual sales of $18.6 million in the United States, according to IMS MAT.

 

January 16, 2014

A faculty member at Southern Illinois University Edwardsville has been awarded a United States patent for an invention that tackles bacterial contamination.

EDWARDSVILLE, Ill. — Dr. Ronald Worthington, associate professor of pharmaceutical sciences at the School of Pharmacy at Southern Illinois University Edwardsville, obtained U.S. Patent No. 8,563,293 for his invention to protect against bacterial contamination. 

December 16, 2013

The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps.

SILVER SPRING, Md. — The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps, part of a larger effort by the agency to ensure the safety and efficacy of antibacterial products and slow down the rise of antibiotic-resistant bacteria.

November 11, 2013

Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.

DUBLIN — Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.

Shire, headquartered in Ireland, said the $50-per-share acquisition of ViroPharma would strengthen its rare disease portfolio. Exton, Pa.-based ViroPharma's products include the hereditary angioedema drug Cinryze (C1 esterase inhibitor [human]) and Vancocin (vancomycin hydrochloride), used to treat Clostridium difficile-associated diarrhea.

September 17, 2013

Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

ATLANTA — Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

And the costs go beyond human health and life. According to a study by Tufts University, direct healthcare costs and costs to society for lost productivity from the infections could be as high as $55 billion per year.

September 4, 2013

Aptalis Pharma has launched its 10-day drug therapy for treating a gastrointestinal bacterial infection and ulcer condition, the company said.

BRIDGEWATER, N.J. — Aptalis Pharma has launched its 10-day drug therapy for treating a gastrointestinal bacterial infection and ulcer condition, the company said.

Aptalis announced the launch of Pylera 10 Day Therapy PAK (bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride). The drug is approved for use in combination with the proton-pump inhibitor omeprazole in patients with Helicobacter pylori infection and duodenal ulcer disease that is either active or has a history of occurring within the past five years, for eradicating H. pylori.

August 29, 2013

An aggressive species of tick normally found in the South has been spreading into northern states as well, posing a risk to people and pets, according to published reports.

NEW YORK — An aggressive species of tick normally found in the South has been spreading into northern states as well, posing a risk to people and pets, according to published reports.

August 5, 2013

A new treatment for bacterial infections of the vagina is now available, the drug's manufacturer said.

ST. LOUIS — A new treatment for bacterial infections of the vagina is now available, the drug's manufacturer said Monday.

K-V Pharmaceutical Co. subsidiary Ther-Rx Corp. announced the availability of Clindesse (clindamycin phosphate), saying wholesalers have ordered and received it and are distributing it to retail pharmacies. The drug is used to treat bacterial vaginosis in women who are not pregnant. BV results from an overgrowth of several bacterial species and is the most common vaginal infection in women of childbearing age.

August 2, 2013

The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

July 30, 2013

NutraFana Pharmaceuticals recently launched a probiotic formulated specifically for children called FloraTummys Probiotic Sprinkles.

NORTH BERGEN, N.J. — NutraFana Pharmaceuticals recently launched a probiotic formulated specifically for children called FloraTummys Probiotic Sprinkles. 

The product is formulated with Lactobacillus Acidophilus and Bifidobacterium Lactis and retails for a suggested $29.99 for a 30-day supply. 

June 13, 2013

Voices of Meningitis, a public health initiative of the National Association of School Nurses, in collaboration with Sanofi Pasteur, has announced the launch of Get in the Game: Keeping Teens Healthy, a new program to help educate parents on the danger and prevention of meningococcal disease.

SILVER SPRINGS, Md. and SWIFTWATER, Pa. — Voices of Meningitis, a public health initiative of the National Association of School Nurses, in collaboration with Sanofi Pasteur, has announced the launch of Get in the Game: Keeping Teens Healthy, a new program to help educate parents on the danger and prevention of meningococcal disease.

May 21, 2013

Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.

NEW YORK — Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.

The researchers, at Yeshiva University's Albert Einstein College of Medicine, determined that vitamin C was able to kill drug-resistant forms of the bacteria that causes tuberculosis in lab culture, publishing their findings in the online journal Nature Communications. They had been looking into how TB bacteria become resistant to isoniazid, a first-line drug used to treat it.

February 25, 2013

Scimera BioScience announced the launch of a novel probiotic formulation, Asprega ProPac, to address the gastrointestinal side effects of antibiotic therapy including antibiotic-associated diarrhea.

MIAMI — Scimera BioScience on Thursday announced the launch of a novel probiotic formulation, Asprega ProPac, to address the gastrointestinal side effects of antibiotic therapy including antibiotic-associated diarrhea. Unique to ProPac, Scimera packages its probiotic in a convenient 10-day course.

December 27, 2012

Biocodex last week sought to set the record straight regarding the use of probiotics with antibiotics.

SAN BRUNO, Calif. — Biocodex last week sought to set the record straight regarding the use of probiotics with antibiotics. 

"There is a common myth that probiotics can't be used with antibiotics," stated Kerry Neville, a registered dietitian in Seattle. "In fact, there are different probiotic options available that can be beneficial before, during, and after antibiotic use, like Florastor."

December 19, 2012

A single lot of a congestion-relief product has been recalled due to bacterial contamination found in a sample, the Food and Drug Administration said Wednesday.

SILVER SPRING, Md. — A single lot of a congestion-relief product has been recalled due to bacterial contamination found in a sample, the Food and Drug Administration said Wednesday.

December 11, 2012

Biotech and vaccines company Nuron Biotech has bought rights from Pfizer for a vaccine to prevent infection by a bacteria that is a major cause of infectious disease around the world.

EXTON, Pa. — Biotech and vaccines company Nuron Biotech has bought rights from Pfizer for a vaccine to prevent infection by a bacteria that is a major cause of infectious disease around the world.

November 7, 2012

The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.

SILVER SPRING, Md. — The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.

September 20, 2012

French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development Thursday to develop drugs for tuberculosis.

NEW YORK — French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development to develop drugs for tuberculosis.

The drug maker and the TB Alliance said the deal will include discovery and development of new drug compounds for the disease, which caused almost 1.5 million deaths globally and affected nearly 9 million in 2010, according to the World Health Organization.

June 6, 2011

The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

SILVER SPRING, Md. — The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

The U.S. regulatory agency said that it has been in "routine contact" with the Centers of Disease Control and Prevention and the European Union to monitor the current outbreak of E. coli O104 and to track any illnesses in the United States that may be related to the outbreak.

April 28, 2011

The Personal Care Products Council and the American Cleaning Institute have teamed up to launch a new website, FightGermsNow.com, to provide consumers, researchers and regulators information on antibacterial soaps and ingredients.

WASHINGTON — The Personal Care Products Council and the American Cleaning Institute have teamed up to launch a new website, FightGermsNow.com, to provide consumers, researchers and regulators information on antibacterial soaps and ingredients.

April 20, 2011

Bainbridge & Knight announced the expansion of its Lichi Super Fruit Diet brand with a probiotic product.

NEW YORK — Bainbridge & Knight announced the expansion of its Lichi Super Fruit Diet brand with a probiotic product.

New Lichi LactoSpore is a gluten- and dairy-free probiotic designed to aid in healthy digestion without uncomfortable bloating. It also helps the immune system fight off infections, the company said, and provides Bacillus coagulans, necessary bacteria.

Lichi LactoSpore probiotic will be available at leading drug stores and supermarkets nationwide.

March 16, 2011

A new documentary film released by Institut Rosell-Lallemand discusses the discovery of beneficial bacteria and the role they play in our bodies, as well as the latest research on their potential to improve our lives.

MONTREAL — A new documentary film released by Institut Rosell-Lallemand discusses the discovery of beneficial bacteria and the role they play in our bodies, as well as the latest research on their potential to improve our lives.

“Microwarriors: The Power of Probiotics,” is available on DVD for an introductory price of $9.99. The film highlights probiotics and their contribution to overall health and well-being, the company said. The film was produced by Health Point Productions, a Los Angeles-based company.

February 15, 2011

Clorox recently launched the "Quick & Dirty" cleaning guide for bachelors on its website.

OAKLAND, Calif. — Clorox recently launched the "Quick & Dirty" cleaning guide for bachelors on its website.

January 19, 2011

A poll released by the American Cleaning Institute found that nearly three-quarters of Americans use antibacterial soap, and many of them wouldn't be happy if the government banned such products.

WASHINGTON — A poll released by the American Cleaning Institute found that nearly three-quarters of Americans use antibacterial soap, and many of them wouldn't be happy if the government banned such products.

The poll, which consisted of 1,000 U.S. adults, ages 18 years and older, found that 74% of consumers use antibacterial soap — with 56% of those respondents using them on a regular basis — and deemed antibacterial soap as a preventive measure to avoid the spread of germs.

Additional findings included:

November 15, 2010

Biopharmaceutical company Oragenics has expanded retail distribution of its oral care probiotic EvoraPlus through an...

TAMPA, Fla. — Biopharmaceutical company Oragenics has expanded retail distribution of its oral care probiotic EvoraPlus through an agreement with Winn-Dixie Stores. EvoraPlus will be sold in select Winn-Dixie locations, beginning in January 2011.